Ignite Creation Date:
2025-12-24 @ 10:57 PM
Ignite Modification Date:
2026-05-25 @ 11:23 AM
Study NCT ID:
NCT04659369
Status:
TERMINATED
Last Update Posted:
2024-04-09
First Post:
2020-11-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Pharmacokinetic, Safety, Immunogenicity and Efficacy of CMAB819 and Nivolumab in R/M HNSCC
Sponsor:
Taizhou Mabtech Pharmaceutical Co.,Ltd
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Squamous Cell Carcinoma of the Head and Neck | View |
Keywords: